Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 3)

Adenocarcinoma, Mucinous (Phase 3)

Anemia (Phase 2)

Anemia, Refractory (Phase 2)

Anemia, Refractory, with Excess of Blasts (Phase 2)

Anus Neoplasms (Phase 3)

Astrocytoma (Phase 3)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Breast Neoplasms, Male (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Ductal (Phase 3)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma in Situ (Phase 3)

Carcinoma, Intraductal, Noninfiltrating (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Central Nervous System Neoplasms (Phase 3)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 3)

Cystadenocarcinoma (Phase 3)

Dermatitis (Phase 3)

Esophageal Neoplasms (Phase 3)

Glioblastoma (Phase 2)

Gliosarcoma (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Leukemia, Myelomonocytic, Juvenile (Phase 2)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Melanoma (Phase 2)

Mesothelioma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Nervous System Neoplasms (Phase 3)

Neurotoxicity Syndromes (Phase 3)

Oligodendroglioma (Phase 3)

Osteoporosis (Phase 3)

Pancoast Syndrome (Phase 2)

Pancreatic Neoplasms (Phase 2)

Pleural Effusion (Phase 3)

Pleural Effusion, Malignant (Phase 3)

Preleukemia (Phase 2)

Primary Myelofibrosis (Phase 2)

Prostatic Neoplasms (Phase 3)

Radiodermatitis (Phase 3)

Rectal Neoplasms (Phase 3)

Small Cell Lung Carcinoma (Phase 3)

Syndrome (Phase 2)